test
Search publications, data, projects and authors

Thesis

English

ID: <

10670/1.uls4pm

>

Where these data come from
Vestibular schwannoma : the evolution of hearing and tumor size in natural course and after treatment by Linac stereotactic radiosurgery

Abstract

objective: Analyse the natural evolution of tumour size and hearing in 151 patients with vestibular schwannome (VS) monitored and evaluate the same parameters for a part of the group treated with LINAC stereotaxic radiosurgery (SRS). Methods: Prospective study of patients tested with MRI and audio vestibular tests for inclusion, during the monitoring period and after SRS. The hearing was graduated according to the Gardner-Robertson (GR) scale and the tumour size according to the Koos scale. Statistical analysis includes survival analysis of Kaplan-Meier, multivariate analysis with linear regression and logistics. Patients with a useful hearing were specifically analysed. Results: During the monitoring period (average 24 months, deviation 6-96), the annual risk of degradation of the GR class was 6 % for GRI patients and 15 % for IBCs. Hearing loss as an initial symptoms was a significant predictive factor for subsequent hearing aggravation (p = 0.003). Tumour growth was 25 % at the last observation during monitoring. For patients treated with LINAC, the preservation of a useful hearing was 51 % to 1 year and 36 % to 3 years. Tumour control was 94 % and 91 % respectively. Conclusion: In patients with VS, hearing loss already present in diagnosis is a negative predictive factor for the evolution of hearing. LINAC stereotaxic radiosurgery is effective for tumour control. Patients who have maintained their pre-treatment status have an annual rate of reduced hearing loss after SRS compares with it before treatment. This suggests a potential protective effect of the SRS, provided that the cochlear function is preserved.

Your Feedback

Please give us your feedback and help us make GoTriple better.
Fill in our satisfaction questionnaire and tell us what you like about GoTriple!